Dutasteride

CHEMBL1200969 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

528.5 g/mol

LogP

5.4

Phase

4

A 5-alpha reductase inhibitor used to treat benign prostatic hyperplasia (BPH) and male pattern hair loss. It works by blocking the conversion of testosterone to dihydrotestosterone, the hormone that causes prostate enlargement and hair loss.

Moleküler Ağırlık

528,5000 g/mol

LogP

5,40

TPSA

58,20 Å²

Lipinski RO5

Başarısız

Terapötik Alanlar

Ovarian Cancer Pancreatic Cancer Bladder Cancer Thyroid Cancer Benign Prostatic Hyperplasia Non-Small Cell Lung Cancer Obesity Breast Cancer HIV/AIDS Prostate Cancer Colorectal Cancer

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

C[C@]12C=CC(=O)N[C@@H]1CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](C(=O)Nc3cc(C(F)(F)F)ccc3C(F)(F)F)CC[C@@H]12

InChI

InChI=1S/C27H30F6N2O2/c1-24-11-9-17-15(4-8-21-25(17,2)12-10-22(36)35-21)16(24)6-7-19(24)23(37)34-20-13-14(26(28,29)30)3-5-18(20)27(31,32)33/h3,5,10,12-13,15-17,19,21H,4,6-9,11H2,1-2H3,(H,34,37)(H,35,36)/t15-,16-,17-,19+,21+,24-,25+/m0/s1

Molecular Formula

C27H30F6N2O2

HBD / HBA

2 / 8

Döndürülebilir Bağlar

2

Ağır Atomlar

37

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

A 5-alpha reductase inhibitor used to treat benign prostatic hyperplasia (BPH) and male pattern hair loss. It works by blocking the conversion of testosterone to dihydrotestosterone, the hormone that causes prostate enlargement and hair loss.

Yes, Dutasteride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200969. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 6918296. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Dutasteride PillFYI'da

Yapı

Hızlı Veriler

Formül: C27H30F6N2O2
Eş Anlamlılar: 3

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.